CELG : Summary for Celgene Corporation - Yahoo Finance

U.S. Markets closed

Celgene Corporation (CELG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
123.15+0.89 (+0.73%)
At close: 4:00PM EDT

123.15 0.00 (0.00%)
After hours: 4:16PM EDT

People also watch
GILDBIIBREGNAMGNALXN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close122.26
Open123.63
Bid122.81 x 100
Ask123.91 x 500
Day's Range122.99 - 123.90
52 Week Range94.42 - 127.64
Volume2,923,706
Avg. Volume3,714,696
Market Cap95.81B
Beta1.53
PE Ratio (TTM)49.46
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Celgene (CELG) to Post Q1 Earnings: What's in the Cards?
    Zacks1 hour ago

    Celgene (CELG) to Post Q1 Earnings: What's in the Cards?

    Celgene Corporation (CELG) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell.

  • Capital Cube1 hour ago

    Celgene Corp. – Value Analysis (NASDAQ:CELG) : April 24, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Celgene Corp. a score of 78. Our analysis is based on comparing Celgene Corp. with the following peers – Amgen Inc., Gilead Sciences, Inc., Biogen Inc., OncoMed Pharmaceuticals, Inc., Eli Lilly and Company, Alexion Pharmaceuticals, Inc., Johnson & Johnson, Illumina, Inc., Novartis AG Sponsored ADR and Acceleron ... Read more (Read more...)

  • Better Buy: Gilead Sciences vs. Celgene
    Motley Fool3 hours ago

    Better Buy: Gilead Sciences vs. Celgene

    These two biopharmaceutical stocks have been going in opposite directions, which has left one trading at a bargain valuation.